Article Information
History
- May 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alicia Roselló1,#,
- Rosanna C. Barnard1,
- David R. M. Smith2,3,4,
- Stephanie Evans5,
- Fiona Grimm6,
- Nicholas G. Davies1,
- Centre for Mathematical Modelling of Infectious Diseases COVID-19 modelling working group*,
- Sarah R. Deeny6,
- Gwenan M. Knight1 and
- W. John Edmunds1
- 1Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
- 2Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
- 3Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
- 4Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
- 5Healthcare Associated Infection and Antimicrobial Resistance Department, Public Health England, London, England
- 6The Health Foundation, London, UK
- ↵#Corresponding author; email: alicia.rosello{at}lshtm.ac.uk